The significant Increase in the expression of genes such as GZMB (granzyme B) and GNLY (granulysin) in CD8+ T cells of patients unresponsive to anti-PD1 treatment could reflect an attempt by the immune system to fight the tumor through the activation of CD8+ T cells. Here, CD8A is linked to neoplasm.